Key result
Endothelial VEGFR2 blockade reduces angiogenesis and inhibits adipose tissue formation in mice.
Answers are grounded in this paper and cite their sources.
Demonstrates reciprocal paracrine regulation between angiogenesis and adipogenesis in a mouse model, indicating that VEGF-VEGFR2 blockade can suppress adipose tissue formation.
With an increasing incidence of obesity worldwide, rational strategies are needed to control adipogenesis. Growth of any tissue requires the formation of a functional and mature vasculature. To gain mechanistic insight into the link between active adipogenesis and angiogenesis, we developed a model to visualize noninvasively and in real time both angiogenesis and adipogenesis using intravital microscopy. Implanted murine preadipocytes induced vigorous angiogenesis and formed fat pads in a mouse dorsal skin-fold chamber. The newly formed vessels subsequently remodeled into a mature network consisting of arterioles, capillaries, and venules, whereas the preadipocytes differentiated into adipocytes as confirmed by increased aP2 expression. Inhibition of adipocyte differentiation by transfection of preadipocytes with a peroxisome proliferator-activated receptor gamma dominant-negative construct not only abrogated fat tissue formation but also reduced angiogenesis. Surprisingly, inhibition of angiogenesis by vascular endothelial growth factor receptor-2 (VEGFR2) blocking antibody not only reduced angiogenesis and tissue growth but also inhibited preadipocyte differentiation. We found that part of this inhibition stems from the paracrine interaction between endothelial cells and preadipocytes and that VEGF-VEGFR2 signaling in endothelial cells, but not preadipocytes, mediates this process. These findings reveal a reciprocal regulation of adipogenesis and angiogenesis, and suggest that blockade of VEGF signaling can inhibit in vivo adipose tissue formation. The full text of this article is available online at http://www.circresaha.org.
No takes yet. Share an insight, caveat, or question.
Fukumura et al. (2003) studied Adipogenesis and obesity. VEGFR2 blocking antibody and PPAR-gamma dominant-negative construct transfection was evaluated on Angiogenesis and preadipocyte differentiation into fat tissue. Blockade of VEGFR2 signaling in endothelial cells reduced angiogenesis and inhibited in vivo preadipocyte differentiation and fat tissue formation in a murine model.
Synapse has enriched 10 related papers. Consider them for comparative context: